1. Home
  2. STN vs EXEL Comparison

STN vs EXEL Comparison

Compare STN & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STN
  • EXEL
  • Stock Information
  • Founded
  • STN 1954
  • EXEL 1994
  • Country
  • STN Canada
  • EXEL United States
  • Employees
  • STN N/A
  • EXEL N/A
  • Industry
  • STN Military/Government/Technical
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • STN Consumer Discretionary
  • EXEL Health Care
  • Exchange
  • STN Nasdaq
  • EXEL Nasdaq
  • Market Cap
  • STN 12.8B
  • EXEL 10.4B
  • IPO Year
  • STN N/A
  • EXEL 2000
  • Fundamental
  • Price
  • STN $109.40
  • EXEL $38.12
  • Analyst Decision
  • STN
  • EXEL Buy
  • Analyst Count
  • STN 0
  • EXEL 23
  • Target Price
  • STN N/A
  • EXEL $44.10
  • AVG Volume (30 Days)
  • STN 139.8K
  • EXEL 3.0M
  • Earning Date
  • STN 11-13-2025
  • EXEL 11-04-2025
  • Dividend Yield
  • STN 0.57%
  • EXEL N/A
  • EPS Growth
  • STN 29.73
  • EXEL 81.76
  • EPS
  • STN 2.80
  • EXEL 2.08
  • Revenue
  • STN $4,511,386,797.00
  • EXEL $2,230,005,000.00
  • Revenue This Year
  • STN $12.60
  • EXEL $9.14
  • Revenue Next Year
  • STN $10.55
  • EXEL $12.51
  • P/E Ratio
  • STN $39.10
  • EXEL $18.32
  • Revenue Growth
  • STN 13.47
  • EXEL 10.73
  • 52 Week Low
  • STN $73.18
  • EXEL $31.90
  • 52 Week High
  • STN $114.52
  • EXEL $49.62
  • Technical
  • Relative Strength Index (RSI)
  • STN 44.10
  • EXEL 46.88
  • Support Level
  • STN $111.31
  • EXEL $33.76
  • Resistance Level
  • STN $114.27
  • EXEL $40.63
  • Average True Range (ATR)
  • STN 1.94
  • EXEL 1.31
  • MACD
  • STN -0.28
  • EXEL 0.07
  • Stochastic Oscillator
  • STN 13.96
  • EXEL 63.54

About STN Stantec Inc

Stantec Inc is a sustainable engineering, architecture, and environmental consulting company. It offers services through the following business operating units; Environmental Services, Infrastructure, Water, Buildings, and Energy & Resources. Maximum revenue is derived from its Infrastructure business unit, which is engaged in evaluating, planning, and designing infrastructure solutions for transportation, community development, and urban spaces. The company's reportable segments are the United States, which derives maximum revenue, Canada, and Global. These segments provide consulting in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics services in the area of infrastructure and facilities.

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Share on Social Networks: